Malaria, Cerebral: Clinical Trials

4 trials for Malaria, Cerebral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow Malaria, Cerebral: new trials by email Literature Review of Malaria, Cerebral trials Research Report on Malaria, Cerebral

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DON in Pediatric Cerebral Malaria
6-diazo-5-oxo-L-norleucine (DON), Placebo - Malaria, Cerebral
Phase 1 / Phase 2RecruitingDouglas Postels, MD, MS1522022-08-162026-10-23
Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria
LEVETIRACETAM - Seizure, Epilepsy
Phase 1 / Phase 2CompletedUniversity of Rochester72013-01-012016-09-15
Study of the Safety of Intravenous Artesunate
Intravenous Artesunate, Placebo - Malaria, Malaria, Cerebral
Phase 1CompletedU.S. Army Medical Research and Development Command262006-06-122018-10-25
Study of the Safety of Intravenous Artesunate
Intravenous artesunate - Malaria, Malaria, Cerebral
Phase 1CompletedU.S. Army Medical Research and Development Command402016-10-26

Narrower conditions

Malaria (3)  ·  Epilepsy (1)  ·  Malaria, Falciparum (1)  ·  Seizures (1)

Broader conditions

Central Nervous System Diseases (4)  ·  Central Nervous System Infections (4)  ·  Central Nervous System Parasitic Infections (4)  ·  Central Nervous System Protozoal Infections (4)  ·  Infections (4)  ·  Mosquito-Borne Diseases (4)  ·  Nervous System Diseases (4)  ·  Parasitic Diseases (4)  ·  Protozoan Infections (4)  ·  Vector Borne Diseases (4)  ·  Brain Diseases (1)  ·  Malaria (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Diazooxonorleucine (1)  ·  Levetiracetam (1)  ·  Mannitol (1)  ·  Sodium Chloride (1)

Sponsors

U.S. Army Medical Research and Development Command (2)  ·  Douglas Postels, MD, MS (1)  ·  University of Rochester (1)

Countries

Malawi (2)  ·  United States (2)

Top investigators

Peter J Weina, MD, PhD (2)  ·  Douglas Postels, MD (1)  ·  Gretchen L Birbeck, M.D. (1)

Results publications

PMID 31672143, PMID 38279124, PMID 41748157

NIH funding

R01NS074409 (1)